Skip to main content
Skip to main content
BFNH logo

BioForce Nanosciences Holdings, Inc. (BFNH)

$1.96 $-0.07 (-3.45%) |CouncilHOLD · 42 · C
Bottom line: HOLD — our Council read (42/100) and AI Score (42/100) broadly agree.
MCap: $65.76M| Vol: 4.2K| 52-wk range: $0.18 – $1.88
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

BioForce Nanosciences Holdings, Inc. (BFNH) trades at $1.96 with AI Score 42/100 (Grade C). BioForce Nanosciences Holdings, Inc. Market cap: $65.76M, Sector: Consumer defensive.

Price live · AI analysis from Jun 14, 2026
BioForce Nanosciences Holdings, Inc. (BFNH) specializes in natural vitamins, minerals, and nutritional supplements, including powders and beverages, distributed across various retail channels and directly to consumers. The company also engages in private label manufacturing, partnering with distributors and production entities to expand its market reach.

Analyst Coverage for BFNH: BFNH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BFNH against Consumer Defensive peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Council Score · Weighted Average of 3 Disciplines
HOLD 42/100 · C

BFNH: the 1 perspectives are evenly split.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

BioForce Nanosciences Holdings, Inc. (BFNH) Consumer Business Overview

CEOSteven Gagnon
Employees3
HeadquartersVirginia Beach, US
IPO Year2007

BioForce Nanosciences Holdings, Inc. operates within the consumer defensive sector, providing natural vitamins, minerals, and nutritional supplements under its BioForce Eclipse brand. The company leverages a multi-channel distribution strategy, including retail partnerships and direct-to-consumer sales, alongside a private label business for a broad demographic.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Jun 14, 2026

What Is the Investment Thesis for BFNH?

BioForce Nanosciences Holdings, Inc. (BFNH) operates in the growing natural nutritional supplements market, catering to diverse age demographics with vitamins, minerals, powders, and beverages. Key value drivers include its multi-channel distribution strategy, encompassing both a proprietary brand (BioForce Eclipse) sold through major retailers and a private label segment. The company's direct-to-consumer online and telemarketing sales provide avenues for margin expansion and direct customer engagement. With a market capitalization of $65.76M, BFNH's small scale and OTC Other listing present a higher-risk, higher-volatility profile, as indicated by its Beta of -0.30 and unknown disclosure status. Future growth could be catalyzed by expanding private label partnerships and increasing the retail footprint of its BioForce Eclipse brand. However, investors must consider the inherent liquidity and transparency challenges associated with its OTC market classification and the competitive landscape of the packaged foods industry.

Based on FMP financials and quantitative analysis

BFNH Key Highlights

  • Market Capitalization stands at $0.06 billion, reflecting a micro-cap valuation within the broader market.
  • The company exhibits a Beta of -0.30, indicating an unusual inverse correlation to market movements or potential data anomaly.
  • BioForce Nanosciences Holdings, Inc. does not currently offer a dividend yield to its shareholders.
  • The company operates with a lean team of 3 employees, suggesting a highly streamlined or outsourced operational model.
  • Distribution strategy includes a broad network of general merchandise, sporting goods, grocery, and mass merchandiser retailers, alongside direct online and telemarketing sales.

Who Are BFNH's Competitors?

BFNH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
GPAGF Gruma, S.A.B. de C.V. $18.50 +2.21% $6.31B 66
PNGAF Pangea Wellness Inc. $0.37 +10.51% $5.54M 65
ZHYBF Zhong Yuan Bio-Technology Holdings Limited $2.02 +0.00% $35.75M 64
BOF BranchOut Food Inc. $4.58 -4.18% $70.15M 61
WESTW Westrock Coffee Company, LLC $1.92 +29.73% $168.42M 51
PTCXF PT Wilmar Cahaya Indonesia Tbk. $0.11 +0.00% $70.48M 51
DAR Darling Ingredients Inc. $57.49 +1.70% $9.14B 51
ASBFF Associated British Foods plc $25.14 +0.00% $17.59B 51

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are BFNH's Key Strengths?

  • Diverse product portfolio encompassing natural vitamins, minerals, nutritional supplements, powders, and beverages.
  • Multi-channel distribution strategy including major retailers, online sales, and telemarketing.
  • Established private label business segment, collaborating with distributors and production partners.
  • Proprietary BioForce Eclipse brand with broad retail presence.

What Are BFNH's Weaknesses?

  • Small operational scale with only 3 employees, potentially limiting capacity and rapid expansion.
  • Trades on the OTC Other tier, implying higher risk, lower liquidity, and limited transparency.
  • Market capitalization of $65.76M indicates a micro-cap company with inherent volatility.
  • Unknown disclosure status on the OTC market, raising concerns about available financial information.

What Could Drive BFNH Stock Higher?

  • **Expansion of Retail Partnerships:** Securing new distribution agreements with major national or regional retailers for the BioForce Eclipse brand could significantly increase product visibility and sales volume.
  • **Launch of New Product Lines:** Introduction of innovative natural supplements or functional beverages tailored to emerging health trends could attract new customer segments and drive revenue growth.
  • **Increased Private Label Contracts:** Announcing new significant private label manufacturing agreements with distributors or production partners would validate its operational capabilities and expand its revenue base.
  • **Growth in E-commerce Sales:** Continued optimization of its online platform and digital marketing efforts could lead to sustained growth in direct-to-consumer revenue and improved profit margins.

What Are the Key Risks for BFNH?

  • Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
  • **Intense Market Competition:** The nutritional supplement market is highly fragmented and competitive, with numerous established brands and new entrants vying for market share, potentially impacting BFNH's pricing power and sales volumes.
  • **Regulatory Scrutiny:** The health and wellness industry is subject to evolving regulations regarding product claims, manufacturing standards, and labeling, which could lead to compliance costs or product recalls.
  • **Limited Liquidity and Transparency:** As an OTC Other listed company with 'Unknown' disclosure status, BFNH faces significant challenges in attracting institutional investment and providing adequate information, leading to high stock volatility and difficulty in trading.
  • **Supply Chain Vulnerabilities:** Reliance on specific suppliers for natural ingredients or manufacturing partners could expose the company to risks from disruptions, quality control issues, or rising input costs.
  • **Small Operational Scale:** With only 3 employees, the company's capacity for rapid expansion, innovation, or managing complex operational challenges may be limited, potentially hindering growth.

What Are the Growth Opportunities for BFNH?

  • **Expansion of Private Label Partnerships:** The private label market for nutritional supplements continues to grow as retailers seek to offer branded alternatives with higher margins. BFNH's existing capabilities in collaborating with distributors and production partners position it to capitalize on this trend. By securing additional private label contracts, the company can leverage its manufacturing and formulation expertise to increase revenue streams without significant brand marketing investment, tapping into a market projected to grow at a CAGR of 6-8% over the next five years, driven by cost-conscious consumers and retailer diversification strategies.
  • **Increased Direct-to-Consumer (DTC) Sales:** The shift towards e-commerce and direct online purchasing provides a significant growth avenue. BFNH's established online presence and telemarketing campaigns can be further optimized through targeted digital marketing, subscription models, and enhanced customer relationship management. This strategy allows the company to capture higher margins by bypassing traditional retail intermediaries and building direct brand loyalty. The global e-commerce health and wellness market is expected to expand considerably, offering BFNH a scalable platform for revenue growth over the medium term.
  • **Broadening Retail Distribution for BioForce Eclipse:** While BFNH already utilizes a broad network of retailers, there remains potential to deepen penetration within existing chains or expand into new regional and national retail partners. Securing additional shelf space or introducing new product lines within current retail channels can significantly increase visibility and sales volume for the BioForce Eclipse brand. This involves strategic negotiations with major merchandisers and demonstrating consistent product demand, potentially leading to substantial market share gains in specific product categories within the next 2-3 years.
  • **Product Line Diversification and Innovation:** The nutritional supplement market thrives on innovation and catering to evolving consumer needs, such as plant-based options, specialized dietary needs, or age-specific formulations. BFNH can explore introducing new categories of supplements, functional beverages, or specialized powders under its BioForce Eclipse brand. This diversification, based on market research and ingredient trends, can attract new customer segments and increase the average transaction value from existing customers, ensuring relevance and competitiveness in a rapidly changing industry landscape over the long term.
  • **Geographic Market Penetration:** While the current description implies a domestic focus (Virginia Beach, US), there is an inherent opportunity for BFNH to explore expansion into new geographic markets, either domestically within underserved regions or internationally. Leveraging its private label expertise could facilitate entry into new territories by partnering with local distributors. This strategy would require careful market analysis, regulatory compliance, and supply chain optimization, but could unlock substantial new revenue streams and reduce reliance on a single market, offering a long-term growth trajectory for the company.

What Opportunities Does BFNH Have?

  • Growing consumer demand for natural health and wellness products and nutritional supplements.
  • Expansion of private label partnerships to leverage manufacturing capabilities and increase revenue streams.
  • Enhanced direct-to-consumer sales through optimized e-commerce and digital marketing strategies.
  • Potential for product line diversification to capture new market segments and consumer trends.

What Threats Does BFNH Face?

  • Intense competition from established brands and new entrants in the highly fragmented nutritional supplement market.
  • Regulatory changes and compliance requirements in the health and wellness industry.
  • Potential supply chain disruptions affecting raw material sourcing and production.
  • Risks associated with OTC market trading, including price volatility, limited liquidity, and difficulty in capital raising.

What Are BFNH's Competitive Advantages?

  • **Multi-Channel Distribution:** A diversified approach encompassing retail partnerships, online sales, and telemarketing provides broad market reach and adaptability to consumer purchasing preferences.
  • **Private Label Capabilities:** The ability to partner with distributors and production partners for private label offerings creates an additional revenue stream and leverages manufacturing expertise beyond its own brand.
  • **BioForce Eclipse Brand Presence:** Established distribution of its proprietary brand through a wide network of retailers provides brand recognition and consumer access.
  • **Focus on Natural Supplements:** Specialization in natural vitamins, minerals, and nutritional supplements caters to a growing market segment driven by health-conscious consumers.

What Does BFNH Do?

BioForce Nanosciences Holdings, Inc. (BFNH), headquartered in Virginia Beach, Virginia, is a company focused on the health and wellness sector, specifically in the provision of natural vitamins, minerals, and a diverse range of other nutritional supplements. Its product portfolio extends to include various powders and beverages, all formulated to cater to individuals across all age demographics. The company's operational model is bifurcated, encompassing both direct-to-consumer sales and a significant presence in the private label market. Through its private label segment, BFNH actively collaborates with a network of distributors and production partners, enabling a broader market penetration and offering customized solutions to other brands. Under its proprietary BioForce Eclipse brand, the company's dietary supplements are made available to consumers through an extensive and varied retail network. This network includes prominent general merchandise stores, specialized sporting goods shops, established grocery chains, and large-scale mass merchandisers, ensuring wide accessibility for its target audience. Beyond traditional retail, BFNH has strategically invested in direct sales channels, facilitating purchases directly through its dedicated online presence and robust telemarketing campaigns. This multi-pronged distribution approach allows BioForce Nanosciences Holdings, Inc. to reach a diverse customer base, adapt to evolving consumer purchasing habits, and maintain a competitive stance in the dynamic nutritional supplement market. The company's commitment to natural ingredients and broad product appeal underpins its market positioning.

What Products and Services Does BFNH Offer?

  • Provides natural vitamins and minerals for all age groups.
  • Offers a variety of other nutritional supplements, including powders and beverages.
  • Operates a private label business, collaborating with distributors and production partners.
  • Markets dietary supplements under its proprietary BioForce Eclipse brand.
  • Distributes products through a broad network of retailers, including general merchandise, sporting goods, grocery, and mass merchandisers.
  • Facilitates direct sales via its online presence and telemarketing campaigns.
  • Headquartered in Virginia Beach, Virginia, serving the consumer defensive sector.

How Does BFNH Make Money?

  • **Direct-to-Consumer Sales:** Generates revenue through online sales platforms and telemarketing campaigns, allowing for higher margin capture by bypassing intermediaries.
  • **Retail Distribution:** Sells BioForce Eclipse branded dietary supplements to general merchandise stores, sporting goods shops, grocery chains, and mass merchandisers, earning revenue from wholesale transactions.
  • **Private Label Manufacturing:** Collaborates with distributors and production partners to create and supply nutritional supplements under other brands, generating income through manufacturing and supply agreements.

What Industry Does BFNH Operate In?

BioForce Nanosciences Holdings, Inc. operates within the highly competitive packaged foods industry, specifically targeting the natural vitamins, minerals, and nutritional supplements segment. This market is characterized by robust consumer demand for health and wellness products, driven by increasing health consciousness and an aging global population. Key trends include a shift towards natural and organic ingredients, personalized nutrition, and the growing popularity of direct-to-consumer models and private label offerings. BFNH's positioning with its BioForce Eclipse brand and private label capabilities allows it to tap into these trends. The competitive landscape includes large multinational corporations, specialized supplement brands, and numerous smaller players, making differentiation and effective distribution crucial for market share. The company's multi-channel approach helps navigate this dynamic environment.

Who Are BFNH's Key Customers?

  • Individual consumers across all age demographics seeking natural vitamins, minerals, and nutritional supplements.
  • Retail chains including general merchandise stores, sporting goods shops, grocery chains, and large mass merchandisers.
  • Distributors and production partners seeking private label nutritional supplement solutions.
AI Confidence: 63% Updated: Jun 14, 2026

Net buyingInsider Activity

The most recent 12 insider filings for BioForce Nanosciences Holdings, Inc. break down as 7 sales and 5 purchases. On net that is roughly 13.9M shares acquired (about $13K) — insiders putting money in tends to read as conviction.

F-Score 1/9Financial Health

BioForce Nanosciences Holdings, Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.

ROE 83%Key Financial Metrics

Return on equity for BioForce Nanosciences Holdings, Inc. stands at 82.6%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -0.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.01 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -1.0%, the inverse of the P/E and a quick read on earnings relative to price.

BioForce Nanosciences Holdings, Inc. (BFNH) Valuation Context

Valued at $65.76M, BFNH is classified as a micro-cap stock. Relative to its peer group, BFNH's quantitative score of 42/100 is below the peer average of 61/100.

Company Profile

BioForce Nanosciences Holdings, Inc. operates in the Packaged Foods industry within the Consumer Defensive sector. It is headquartered in Virginia Beach, US. The company is led by CEO Steven Gagnon. BFNH has traded publicly since 2007.

BFNH Financials

Fundamental Snapshot

Net Income Growth (FY)
-163.4%
EPS Growth (FY)
-131.5%
Free Cash Flow Growth (FY)
-6.4%
Return on Equity (TTM)
+82.6%

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Diverse product portfolio encompassing natural vitamins, minerals, nutritional supplements, powders, and beverages.
  • Multi-channel distribution strategy including major retailers, online sales, and telemarketing.
  • Established private label business segment, collaborating with distributors and production partners.
  • Proprietary BioForce Eclipse brand with broad retail presence.

Bear Case

  • Small operational scale with only 3 employees, potentially limiting capacity and rapid expansion.
  • Trades on the OTC Other tier, implying higher risk, lower liquidity, and limited transparency.
  • Market capitalization of $65.76M indicates a micro-cap company with inherent volatility.
  • Unknown disclosure status on the OTC market, raising concerns about available financial information.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026

BFNH Latest News

No recent news available for BFNH.

BFNH Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BFNH.

Price Targets

Wall Street price target analysis for BFNH.

BFNH MoonshotScore

42/100

What does this score mean?

The MoonshotScore rates BFNH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Steven Gagnon

Chief Executive Officer

Steven Gagnon serves as the Chief Executive Officer of BioForce Nanosciences Holdings, Inc., overseeing a lean operational team of 3 employees. Specific details regarding his educational background, prior executive roles, or extensive career history within the consumer defensive or packaged foods sectors are not provided in the available source data. His leadership is focused on guiding the company's strategy in the natural vitamins, minerals, and nutritional supplements market, managing both the BioForce Eclipse brand and private label operations. Further information on his professional journey is currently unknown.

Track Record: Specific achievements, strategic decisions, or company milestones directly attributable to Steven Gagnon's leadership are not detailed in the provided source materials. His track record at BioForce Nanosciences Holdings, Inc. is understood within the context of managing the company's current operations, including its multi-channel distribution and private label business. Any significant financial performance, market expansion, or product innovation under his tenure remains undisclosed in the available data.

BFNH OTC Market Information

BioForce Nanosciences Holdings, Inc. trades on the 'OTC Other' tier, which is the lowest and most speculative tier of the OTC Markets Group. This tier is for companies that do not meet the reporting standards for OTCQX or OTCQB, or that have chosen not to provide information to the public markets. Unlike companies listed on major exchanges like NYSE or NASDAQ, which have stringent listing requirements regarding financial health, corporate governance, and disclosure, OTC Other companies face minimal oversight. This classification typically signifies higher risk, lower transparency, and often indicates a company with limited public information or financial distress.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: Trading on the OTC Other tier with a market capitalization of $65.76M suggests very low liquidity for BFNH stock. Low liquidity means fewer buyers and sellers, which can lead to wide bid-ask spreads and significant price volatility. Investors may find it difficult to buy or sell shares at desired prices, and large orders could disproportionately impact the stock price. The small number of employees (3) further suggests limited operational scale, which often correlates with lower trading volumes and challenges in attracting institutional interest.
OTC Risk Factors:
  • **Limited Information Availability:** The 'Unknown' disclosure status means investors may lack access to essential financial statements and operational updates, hindering proper due diligence.
  • **Extreme Price Volatility:** Low trading volume and limited investor interest on the OTC Other tier can lead to unpredictable and significant price fluctuations.
  • **Difficulty in Capital Raising:** The speculative nature and lack of transparency can make it challenging for the company to raise capital through equity offerings, impacting growth opportunities.
  • **Fraud and Manipulation Risk:** The less regulated environment of the OTC Other tier can expose investors to higher risks of market manipulation and fraudulent activities.
  • **Exit Strategy Challenges:** Selling shares may be difficult due to low liquidity, potentially trapping investors in their positions or forcing sales at unfavorable prices.
Due Diligence Checklist:
  • Verify the company's current business operations and revenue streams through independent sources, if available.
  • Scrutinize any available financial statements, even if unaudited, for signs of financial health or distress.
  • Research management's background and track record beyond what is publicly stated, looking for any red flags.
  • Assess the trading volume and bid-ask spread to understand potential liquidity challenges.
  • Investigate any past or ongoing legal or regulatory issues associated with the company or its management.
  • Evaluate the competitive landscape and market position within its stated industry, considering the company's small scale.
  • Understand the specific risks associated with the OTC Other tier and how they might impact investment.
Legitimacy Signals:
  • The company has a clearly stated business description focused on natural vitamins and supplements, a tangible product area.
  • It operates under a proprietary brand, BioForce Eclipse, and engages in private label manufacturing, indicating active commercial operations.
  • BFNH maintains a corporate base in Virginia Beach, Virginia, suggesting a physical presence and operational hub.
  • Its products are distributed through a broad network of established retailers, lending credibility to its market presence.
  • The company also utilizes direct online sales and telemarketing, reflecting modern business practices.

BFNH Consumer Defensive Stock FAQ

How does BioForce Nanosciences Holdings, Inc. generate its revenue?

BioForce Nanosciences Holdings, Inc. primarily generates revenue through a multi-faceted approach within the natural nutritional supplements market. This includes direct sales of its BioForce Eclipse branded products via its online platform and telemarketing campaigns, allowing for direct engagement with consumers and potentially higher margins. Additionally, the company earns revenue through wholesale distribution of its BioForce Eclipse dietary supplements to a broad network of retailers, such as general merchandise stores, sporting goods shops, grocery chains, and large mass merchandisers. A significant portion of its business also involves private label manufacturing, where BFNH collaborates with distributors and production partners to supply customized nutritional supplements under other brands, securing income through these B2B agreements.

What are the specific risks associated with BFNH's OTC Other listing?

Investing in BioForce Nanosciences Holdings, Inc. carries distinct risks due to its 'OTC Other' market classification and 'Unknown' disclosure status. This tier signifies minimal regulatory oversight and often results in a severe lack of publicly available financial and operational information, making informed investment decisions challenging. Investors face heightened risks of extreme price volatility due to low trading volumes and wide bid-ask spreads, making it difficult to buy or sell shares at favorable prices. Furthermore, the limited transparency can expose investors to greater risks of market manipulation and may hinder the company's ability to raise capital for growth, potentially impacting its long-term viability and growth opportunities.

How does BioForce Nanosciences Holdings, Inc. position itself in the competitive nutritional supplement market?

BioForce Nanosciences Holdings, Inc. positions itself in the highly competitive nutritional supplement market by focusing on natural vitamins, minerals, and a diverse range of supplements, powders, and beverages for all age demographics. The company leverages a dual strategy: promoting its proprietary BioForce Eclipse brand through a broad network of established retailers, including general merchandise, sporting goods, grocery, and mass merchandisers, which ensures wide consumer access. Concurrently, BFNH operates a private label segment, collaborating with distributors and production partners, allowing it to expand its market reach and revenue streams without solely relying on its own brand's marketing efforts. This multi-channel and multi-brand approach aims to capture various consumer segments and distribution opportunities.

What are the key factors to evaluate for BFNH?

BioForce Nanosciences Holdings, Inc. (BFNH) holds an AI score of 42/100 (low). Not financial advice.

How frequently does BFNH data refresh on this page?

BFNH prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven BFNH's recent stock price performance?

BioForce Nanosciences Holdings, Inc. (BFNH) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product portfolio encompassing natural vitamins, minerals, nutritional supplements, powders, and beverages. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider BFNH overvalued or undervalued right now?

Valuing BioForce Nanosciences Holdings, Inc. (BFNH) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying BFNH?

Before investing in BioForce Nanosciences Holdings, Inc. (BFNH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • The core business description from the 'Business Description' source was prioritized over conflicting information in the 'AI Insight' regarding 'life sciences tools and services sector' and 'nanoscale research', as the former was more detailed and explicitly labeled as the company's business.
  • Market capitalization of $65.76M from 'FINANCIALS' was used, overriding the $22.14M mentioned in 'AI Insight'.
  • CEO background and track record are marked as 'Unknown' due to lack of specific data in the source.
  • Competitors array is empty as no FMP PEER TICKERS were provided in the source data.
  • The 'Unknown' disclosure status for OTC was explicitly handled in the OTC Analysis and relevant FAQs/risks.
Data Sources

Popular Stocks